Andromeda Metals (ADN) Q4 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 TU earnings summary
31 Jul, 2026Executive summary
Advanced the Great White Project (GWP) and High Purity Alumina (HPA) Project, completing key early works and pilot plant commissioning.
Reduced required equity funding for GWP Stage 1A+ to ~$40 million, with a $75 million debt facility credit-approved.
Engaged with a Middle East-based cornerstone investor for asset-level investment, with negotiations delayed by geopolitical events.
Implemented cost-saving measures, achieving ~$3 million in savings across early works, procurement, and admin costs.
Financial highlights
Cash and cash equivalents at quarter end: $3.2 million, down from $5.2 million in the previous quarter.
Net cash used in operating activities: $721k; investing activities: $1,227k; financing activities: $56k.
Received $1.66 million R&D tax refund, based on $3.4 million eligible R&D expenditure in FY2025.
Exploration and evaluation expenditure: $2.61 million, mainly for early works payments.
Outlook and guidance
Targeting commercial 4N HPA samples for customer evaluation in H2 2026.
Ongoing evaluation of funding and strategic initiatives to secure equity for GWP development.
Board expects funding initiatives to provide sufficient capital to meet business objectives.
Latest events from Andromeda Metals
- Progress on Great White and HPA projects continued, but funding delays impacted cash flow.ADN
Q3 2026 TU - Construction-ready kaolin project advances with secured offtakes and narrowed net loss.ADN
H2 2024 - Significant impairment and funding needs led to a $101.6 million net loss despite capital raised.ADN
H1 2026 - AGM confirmed strong project economics, secured offtakes, and advancing funding and development.ADN
AGM 2025 - Advancing two high-value mineral projects with secured funding, offtakes, and strong market outlook.ADN
Noosa Mining Investor Conference - Secured major funding, advanced HPA project, and raised $13M to support ongoing development.ADN
Q1 2026 TU - Advancing a de-risked kaolin project and innovative HPA venture with robust market outlook.ADN
Investor Presentation - Net loss narrowed 45% as funding and offtake deals advanced the Great White Project.ADN
H1 2025 - Shovel-ready kaolin project advances with strong economics, secured offtakes, and active funding efforts.ADN
Investor Update